Newsfeeds - Spark Newswire

1 minute read

FDA
News

Repare Therapeutics Issues Statement Regarding Inadvertent Issuance Of Phase 1/2 TRESR RP-3500 Clinical Trial Abstract By AACR-NCI-EORTC Virtual International Conference

Today, 9:51 PM

Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a leading clinical-stage precision oncology company, today issued the following statement concerning the inadvertent issuance of an

RPTX

4 minute read

The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More

By Shanthi Rexaline

Today, 9:51 PM

Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks.

ADVM

2 minute read

Events
News

Repare Therapeutics To Present Initial Data From The Phase 1/2 TRESR RP-3500 Clinical Trial At AACR-NCI-EORTC Virtual International Conference On Molecular Targets And Cancer Therapeutics

By Benzinga Newsdesk

Today, 9:51 PM

Repare Therapeutics Inc. (“Repare” or the “Company”) (NASDAQ:RPTX), a leading clinical-stage precision oncology company, today announced that it has been selected for an oral presentation of

RPTX

11 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 23, 2021

By Benzinga Insights

Today, 9:51 PM

AMGN

1 minute read

Stifel Initiates Coverage On Repare Therapeutics with Buy Rating, Announces Price Target of $48

By Benzinga Newsdesk

Today, 9:51 PM

Stifel analyst Benjamin Burnett initiates coverage on Repare Therapeutics (NASDAQ:RPTX) with a Buy rating and announces Price Target of $48.

RPTX

1 minute read

Cathie Wood’s ARK Invest Posts Fund Purchases For Friday, Sept. 10, 2021: VCYT, CRSP, SPFR, MKFG, RPTX, NVTA, PSNL, ADPT

By Benzinga Newsdesk

Today, 9:51 PM

Veracyte (VCYT) - 45,484 CRISPR Therapeutics (CRSP) - 17,000 Jaws Spitfire Acquisition Corp (SPFR) - 318482 Markforged Holding Corp (MKFG) - 174,225 Repare Therapeutics (RPTX)

ADPT

10 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 13, 2021

By Benzinga Insights

Today, 9:51 PM

ABNB

1 minute read

HC Wainwright & Co. Initiates Coverage On Repare Therapeutics with Buy Rating, Announces Price Target of $54

By vishwanath@benzinga.com

Today, 9:51 PM

HC Wainwright & Co. analyst Robert Burns initiates coverage on Repare Therapeutics (NASDAQ:RPTX) with a Buy rating and announces Price Target of $54.

RPTX

1 minute read

Cathie Wood’s ARK Invest Posts Fund Purchases For Wednesday, Sept. 8, 2021: PATH, NVTA, FATE, PD, DE, MKFG, KMTUY, SPFR, ROKU, SPLK, KVSB, ADPT, SLGC, VCYT, PSNL, RPTX, ETSY, FTCH, STNE, Z, JD, HEI, BLDE, AVAV

By Michael Horton

Today, 9:51 PM

UiPath (PATH) - 1,382,967 Shares Invitae (NVTA) - 616,413 Fate Therapeutics (FATE) - 129,739 PagerDuty (PD) - 55,058 Deere & Co (DE) - 37,991 Markforged (MKFG) - 600,664 Komatsu (KMTUY) - 96,118 Jaws

ADPT

1 minute read

Cathie Wood’s ARK Invest Posts Fund Purchases For Wednesday, Sept. 1, 2021: SGFY, FATE, KMTUY, ACIC, KTOS, KMFG, BLDE, SPFR, GENI, PFE, NVTA, RPTX, PSNL, ADPT, TDOC, Z, PRNT

By Michael Horton

Today, 9:51 PM

Signify Health (SGFY) - 189,960 Shares Fate Therapeutics (FATE) - 1,075 Komatsu (KMTUY) - 175,000 Atlas Crest Investment (ACIC) - 144,000 Kratos Defense & Security Solutions (KTOS) - 41,408 Markforged (MKFG) -

ACIC